Skip to main content
Caplight Logo









Spora Biotech

Spora Biotech

Private
SantiagoEnergy & Sustainabilityhttps://spora.co.uk/

Last Round

Seed

Jun 1, 2022

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Spora Biotech is a biotechnology company that develops sustainable mycelium-based biomaterials and textiles as alternatives to animal and synthetic leather.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Biotechnology, Advanced Materials, Fashion & Beauty, Circular Economy

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

mycelium leathermushroom leatherbio-textilesustainable materialsvegan leathermycelium-based materialsbio-fabricationingredient brandcruelty-free leatherbiotechnologycircular economyalternative leathermaterial sciencebiodegradable materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spora Biotech Comparables

Compare Spora Biotech with similar companies based on industry and business-model similarity.

Spora Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mycotech Lab
88%
SQIM
88%
Polybion
87%

Spora Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 1, 2022
AcceleratorApr 1, 2021

Key People

Founding team and executive leadership

Hernan Rebolledo

Co-founder & CEO

Founding Team

Diego Valdes Puga

Chief Operating Officer

Executive Team

Spora Biotech Investors

Notable investors and investment history

Spora Biotech investors
InvestorRounds
Fen VenturesSeed
AceleraLatamSeed, Accelerator
Fundación ChileSeed
ChileGlobal VenturesSeed
Sunna VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 63% MoM, reaching 2.6K.

  • May 2, 2025

    Monthly visitors grew 226% MoM, reaching 1.9K.

Spora Biotech Filings

Explore SEC and related filing metadata, where available.

Spora Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spora Biotech's valuation, stock price, and market status.

Is Spora Biotech a public or private company?

Spora Biotech is a private company.

What is the current stock price of Spora Biotech?

Spora Biotech is a private company with no public stock price. Caplight tracks Spora Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Spora Biotech worth (valuation)?

Valuation information for Spora Biotech is not publicly available.

Can I buy Spora Biotech stock?

Spora Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spora Biotech's last funding round?

Spora Biotech's most recent funding round was Seed on June 1, 2022.

Who are the main investors in Spora Biotech?

Key investors in Spora Biotech include AceleraLatam.

Will Spora Biotech IPO soon?

No public IPO plans have been announced for Spora Biotech.

How can I track Spora Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spora Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSantiago
Employee Range35
Year Founded2017
Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?